Brugge Clinical Site 203

Bruges 8000

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) — Stopped early
• A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis — Completed